Goldman Sachs Group Inc Imago Bio Sciences, Inc. Transaction History

Goldman Sachs Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 14, 2024	BUY	$15.03 - $35.96 $7.75 Million - $18.5 Million	515,384 Added 2011.25%	541,009 $19.4 Million
Q4 2022 Feb 13, 2023	BUY	$15.03 - $35.96 $7.75 Million - $18.5 Million	515,384 Added 2011.25%	541,009 $19.4 Million
Q3 2022 May 14, 2024	SELL	$14.15 - $19.5 $2.76 Million - $3.8 Million	-195,057 Reduced 88.39%	25,625 $385,000
Q3 2022 Nov 10, 2022	SELL	$14.15 - $19.5 $2.76 Million - $3.8 Million	-195,057 Reduced 88.39%	25,625 $385,000
Q2 2022 May 14, 2024	BUY	$11.81 - $20.92 $2.61 Million - $4.62 Million	220,682 New	220,682 $2.96 Million
Q2 2022 Aug 15, 2022	BUY	$11.81 - $20.92 $1.49 Million - $2.63 Million	125,855 Added 132.72%	220,682 $2.96 Million
Q1 2022 May 16, 2022	BUY	$16.97 - $25.0 $119,893 - $176,625	7,065 Added 8.05%	94,827 $1.83 Million
Q4 2021 Feb 14, 2022	BUY	$16.22 - $29.69 $1.42 Million - $2.61 Million	87,762 New	87,762 $2.08 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.